Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT03652467
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, ≥ 18 years of age.
* The participant must have histologically-confirmed, unresectable HCC
* At least 1 measurable lesion, and overall tumor lesions occupying \< 50% of liver volume
* The participant has provided signed informed consent
* No known allergy to contrast media
* Not pregnant
* No vascular anatomy or bleeding that would preclude catheter placement or emboli injection
Exclusion Criteria:
* Patients receiving concurrent radiotherapy or immunotherapy.
* Patients who have received previous chemotherapy, biological agents, or radiotherapy.
* Prior transarterial chemoembolisation (TACE) or transarterial embolisation (TAE).
* Prior liver transplantation or liver resection.
* Current or recent (within 10 days of study start) use of full-dose anticoagulants for therapeutic purposes.
* Patients with high risk esophageal/gastric varices.
* The participant has central nervous system (CNS) metastases or carcinomatous meningitis
* The participant has poorly-controlled hypertension \[in other words (ie), blood pressure in abnormal range despite medical management\]
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03652467
Study Brief:
Protocol Section:
NCT03652467